Howland Capital Management LLC Viatris Inc Transaction History

Howland Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 17, 2023	BUY	$9.59 - $11.35 $172 - $204	18 Added 0.14%	12,747 $125,000
Q2 2023 Jul 28, 2023	SELL	$9.02 - $10.29 $422,478 - $481,963	-46,838 Reduced 78.63%	12,729 $127,000
Q1 2023 May 05, 2023	SELL	$9.2 - $12.26 $1,426 - $1,900	-155 Reduced 0.26%	59,567 $573,000
Q4 2022 Jan 30, 2023	SELL	$8.72 - $11.56 $27,136 - $35,974	-3,112 Reduced 4.95%	59,722 $664,000
Q3 2022 Oct 17, 2022	BUY	$8.48 - $11.13 $121,230 - $159,114	14,296 Added 29.45%	62,834 $535,000
Q2 2022 Jul 22, 2022	BUY	$9.95 - $12.27 $482,953 - $595,561	48,538 New	48,538 $508,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Howland Capital Management LLC with notifications on news.